7Baggers

Crown Electrokinetics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190930 20200630 20200930 20201231 20210331 20210930 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 -20.67-17.62-14.57-11.52-8.47-5.42-2.370.68Milllion

Crown Electrokinetics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-09-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2019-09-30 
                 
  revenue682,000 94,000  37,000 22,000           
  yoy3000.00%               
  qoq625.53%   68.18%            
  cost of revenue, excluding depreciation and amortization-1,636,000               
  depreciation and amortization-212,000               
  research and development-756,000 -3,754,000 492,000 490,000 541,000 584,000 955,000 1,473,000 1,096,000 787,000 905,194 838,967 423,174 1,372,522 750,395 
  general and administrative-1,783,000               
  income from operations-3,705,000 -6,864,000 -3,433,000 -4,885,000 -4,126,000 -2,951,000 -3,115,000 -4,475,000 -4,567,000 -5,652,000 -5,262,498 -2,696,859 -2,082,786 -9,310,079 -2,396,378 
  yoy-10.20% 132.60% 10.21% 9.16% -9.66% -47.79% -40.81% 65.93% 119.27% -39.29% 119.60%     
  qoq-46.02% 99.94% -29.72% 18.40% 39.82% -5.26% -30.39% -2.01% -19.20% 7.40% 95.13% 29.48% -77.63% 288.51%  
  operating margin %-543.26% -7302.13%  -13202.70% -18754.55%           
  other income:               
  interest expense-860,000 -2,447,000 -2,445,000 -2,508,000 -2,017,000 -1,000 -1,000 -2,000 -3,000 -2,000 -531,367 -340,880 -1,089,804 -1,234,213 -393,320 
  loss on extinguishment of warrant liability    -504,000           
  gain on issuance of convertible notes    64,000           
  change in fair value of warrants-23,000 34,000 2,688,000 2,130,000 5,606,000           
  change in fair value of notes  -40,000 -6,883,000 -117,000           
  other income-24,000 -29,000 -30,000 -28,000 -1,206,000     -49,000 61,443 -483 -54,226   
  total other income-907,000 -2,442,000 574,000 -9,634,000 1,826,000 799,000 -1,000 -2,000 -3,000 -51,000 -15,410,719 -1,156,537 -3,683,696 -1,151,951 -404,802 
  income before income taxes-4,612,000 -9,306,000 -2,859,000 -14,519,000     -4,570,000       
  income tax expense               
  net income-4,612,000 -9,306,000 -2,859,000 -14,519,000 -2,300,000 -2,152,000 -3,116,000 -4,477,000 -4,570,000 -5,703,000 -20,673,217 -3,853,396 -5,766,482 -10,462,030 -2,801,180 
  yoy100.52% 332.43% -8.25% 224.30% -49.67% -62.27% -84.93% 16.18% -20.75% -45.49% 638.02%     
  qoq-50.44% 225.50% -80.31% 531.26% 6.88% -30.94% -30.40% -2.04% -19.87% -72.41% 436.49% -33.18% -44.88% 273.49%  
  net income margin %-676.25% -9900.00%  -39240.54% -10454.55%           
  deemed dividend on series d preferred stock    -6,000           
  cumulative dividends on series a preferred stock-5,000 -5,000 -5,000 -5,000 -4,000           
  cumulative dividends on series b preferred stock-29,000 -29,000 -29,000 -29,000 -20,000           
  cumulative dividends on series c preferred stock-10,000 -10,000 -10,000 -10,000            
  cumulative dividends on series d preferred stock   -53,000 -86,000 -32,000 -23,000         
  cumulative dividends on series f preferred stock-178,000 -82,000 -144,000             
  cumulative dividends on series f-1 preferred stock-26,000 -39,000 -51,000             
  cumulative dividends on series f-2 preferred stock-35,000 -35,000 -44,000             
  net income attributable to common stockholders-4,895,000 -9,506,000 -3,142,000 -14,616,000 -2,416,000 -2,184,000 -3,139,000         
  net income per share-0.13 7.5 -0.94 -18.02 -0.08 -0.09 -0.18 -0.27 -0.29 -0.39 -1.9 -0.45 -0.22 -0.61 -0.24 
  weighted-average shares outstanding, basic and diluted:36,675,540 5,429,259 3,349,195 810,983 29,695,083 17,436,174 17,644,188 16,419,699 15,856,316 14,510,818 8,851,151 8,595,124 25,645,519 17,342,533 11,625,368 
  cost of revenue 13,500  23,000 31,000          153,500 
  gross profit 1,250  14,000            
  yoy               
  qoq               
  gross margin %0% 1.33%  37.84% 0%           
  operating expenses:               
  selling, general and administrative -25,888,000 2,941,000 4,409,000 3,576,000 2,367,000 2,160,000 3,002,000 3,471,000 4,865,000 4,357,304 1,857,892 1,659,612 7,937,557 1,492,483 
  total operating expenses 3,112,250 3,433,000 4,899,000 4,117,000 2,951,000 3,115,000 4,475,000 4,567,000 5,652,000 5,262,498 2,696,859 2,082,786 9,310,079 2,242,878 
  loss on extinguishment of debt   -2,345,000       -13,804,849 -255,046 -179,400 -18,200  
  change in fair value of derivative liability  401,000             
  gross loss    -9,000          -153,500 
  loss on exchange of notes payable for common stock and warrants          -5,836  -1,498,901   
  gain on extinguishment of debt               
  change in fair value of warrant liability          -1,023,188 -598,899 -861,365 122,909 -11,482 
  chang in fair value of derivative liability          9,692.75 38,771    
  loss on conversion of notes             -22,447  

We provide you with 20 years income statements for Crown Electrokinetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Crown Electrokinetics stock. Explore the full financial landscape of Crown Electrokinetics stock with our expertly curated income statements.

The information provided in this report about Crown Electrokinetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.